Last updated: 2026-09-05 08:36:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
GE HealthCare Technologies Inc. (GEHC) operates in the X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $68,84, with a market capitalisation of $31,49B and a P/E ratio of 15,67. Over the past 52 weeks, its price has ranged from $58,75 to $89,77. This page covers its latest market performance, valuation, price trends and company information.
$31,49B | |
$68,99 | |
$94,80 | |
$53,50 | |
$69,72 | |
2,28M | |
4,43M | |
15,67 | |
$89,77 | |
$58,75 | |
0,21% | |
-- |
GE HealthCare Technologies Inc. (GEHC) last closed at $69,72 as of 2026-09-05 00:00:00, unchanged from the previous close of $69,72.
During the latest regular trading session, GEHC traded between $53,50 and $94,80, with a volume of 2,28M shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, GE HealthCare Technologies Inc. (GEHC) moved from $72,48 to $68,84, representing a decline of 5,03% ($3,64).
The stock traded between $68,49 and $73,40 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2,75 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 32,5%
GEHC is currently trading at $68,84, placing it 32,5% of the way from its 52-week low of $58,75 to its 52-week high of $89,77. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
| Industry | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
| Employees | 54000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GE HealthCare Technologies Inc. (GEHC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.